Janus Henderson Group PLC trimmed its position in National Health Investors, Inc. (NYSE:NHI - Free Report) by 67.8% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,209 shares of the real estate investment trust's stock after selling 40,416 shares during the quarter. Janus Henderson Group PLC's holdings in National Health Investors were worth $1,615,000 at the end of the most recent quarter.
Several other institutional investors have also made changes to their positions in the company. Blue Trust Inc. lifted its position in National Health Investors by 2,651.9% in the 2nd quarter. Blue Trust Inc. now owns 743 shares of the real estate investment trust's stock worth $47,000 after buying an additional 716 shares in the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its position in National Health Investors by 16.0% during the second quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 472,959 shares of the real estate investment trust's stock valued at $32,034,000 after purchasing an additional 65,104 shares during the last quarter. Shayne & Jacobs LLC purchased a new position in National Health Investors in the second quarter valued at about $210,000. Lee Danner & Bass Inc. acquired a new position in National Health Investors in the 2nd quarter worth about $5,089,000. Finally, International Assets Investment Management LLC purchased a new stake in shares of National Health Investors during the 2nd quarter worth about $36,000. 62.51% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the company. StockNews.com cut National Health Investors from a "buy" rating to a "hold" rating in a research note on Tuesday, October 15th. Truist Financial increased their price target on shares of National Health Investors from $65.00 to $78.00 and gave the stock a "hold" rating in a research note on Friday, August 30th. Wells Fargo & Company lowered shares of National Health Investors from an "overweight" rating to an "equal weight" rating and lifted their price objective for the company from $81.00 to $86.00 in a research note on Tuesday, October 1st. Finally, Bank of America initiated coverage on shares of National Health Investors in a report on Tuesday, September 24th. They issued a "buy" rating and a $92.00 price objective for the company. Three analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $76.33.
Read Our Latest Analysis on NHI
National Health Investors Stock Performance
Shares of NYSE NHI traded up $0.45 during trading hours on Friday, hitting $72.76. 299,587 shares of the stock were exchanged, compared to its average volume of 199,209. The firm has a market capitalization of $3.30 billion, a P/E ratio of 25.00, a P/E/G ratio of 4.87 and a beta of 1.04. National Health Investors, Inc. has a one year low of $51.59 and a one year high of $86.13. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29. The company's 50 day moving average is $77.01 and its 200 day moving average is $75.45.
National Health Investors (NYSE:NHI - Get Free Report) last issued its quarterly earnings results on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.07 by ($0.42). National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The business had revenue of $63.32 million during the quarter, compared to analyst estimates of $67.93 million. During the same period in the prior year, the business posted $1.08 earnings per share. The company's revenue for the quarter was up 1.7% compared to the same quarter last year. On average, research analysts expect that National Health Investors, Inc. will post 4.42 EPS for the current year.
National Health Investors Dividend Announcement
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 29th. Stockholders of record on Tuesday, December 31st will be given a $0.90 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.60 annualized dividend and a dividend yield of 4.95%. National Health Investors's dividend payout ratio is 123.71%.
National Health Investors Profile
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
Read More
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.